Oppenheimer analyst Hartaj Singh lowered the price target on Cellectis (NASDAQ: CLLS) to $16.00 (from $33.00) while maintaining an Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE